Objective SLE is a systemic autoimmune disease in which the complement system plays a key pathogenic role, yet the ...

Microbial infections, caused by bacteria, viruses, and parasites, pose a significant challenge to global health, affecting millions annually. Despite advancements in medical science, understanding the ...

InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced new in vitro findings demonstrating that izicopan ...

Care Continuity today announced the launch of Readmission IQ, a readmissions management solution that identifies and ...

Small Modular Reactors promise safer, factory-built nuclear power, but critics question their cost and timeline in the race ...

RNA therapies present significant opportunities in targeting a broad range of diseases through various innovative approaches, including antisense oligonucleotides, siRNAs, mRNA vaccines, and aptamers.

An interview with integration vendor Celigo about Aura, its new conversational agent, sparks some thoughts about the future ...

RZOLV Technologies and EMEW Clean Technologies have formed a strategic alliance to develop integrated systems that extract ...

Data Shows TAMP to be a Promising Approach for Local Delivery of Gemcitabine with Reduced Systemic Toxicity in Patients Diagnosed with Locally ...

Springboards, an AI platform for advertising and marketing teams has launched a new “divergence model”, Flint, designed to ...

Odd chemical pathways can give completely unexpected makeovers to some of the most troublesome waste; take, for example, an ...

Explore how landmark judgments reshape legal precedents, blending old rules with new realities and the human stories behind ...